337 related articles for article (PubMed ID: 31511497)
21. Circular RNA Arhgap12 modulates doxorubicin-induced cardiotoxicity by sponging miR-135a-5p.
Wang X; Cheng Z; Xu J; Feng M; Zhang H; Zhang L; Qian L
Life Sci; 2021 Jan; 265():118788. PubMed ID: 33245966
[TBL] [Abstract][Full Text] [Related]
22. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
[TBL] [Abstract][Full Text] [Related]
23. P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.
Zhu W; Zhang W; Shou W; Field LJ
Cardiovasc Res; 2014 Jul; 103(1):81-9. PubMed ID: 24812279
[TBL] [Abstract][Full Text] [Related]
24. Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis.
Zhang WB; Lai X; Guo XF
Oxid Med Cell Longev; 2021; 2021():8860883. PubMed ID: 33574984
[TBL] [Abstract][Full Text] [Related]
25. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
[TBL] [Abstract][Full Text] [Related]
26. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.
Li S; Wang W; Niu T; Wang H; Li B; Shao L; Lai Y; Li H; Janicki JS; Wang XL; Tang D; Cui T
Oxid Med Cell Longev; 2014; 2014():748524. PubMed ID: 24895528
[TBL] [Abstract][Full Text] [Related]
27. MiR-200a-3p Aggravates DOX-Induced Cardiotoxicity by Targeting PEG3 Through SIRT1/NF-κB Signal Pathway.
Fu Q; Pan H; Tang Y; Rong J; Zheng Z
Cardiovasc Toxicol; 2021 Apr; 21(4):302-313. PubMed ID: 33638775
[TBL] [Abstract][Full Text] [Related]
28. Irigenin treatment alleviates doxorubicin (DOX)-induced cardiotoxicity by suppressing apoptosis, inflammation and oxidative stress via the increase of miR-425.
Guo L; Zheng X; Wang E; Jia X; Wang G; Wen J
Biomed Pharmacother; 2020 May; 125():109784. PubMed ID: 32092815
[TBL] [Abstract][Full Text] [Related]
29. MiR-24-3p Attenuates Doxorubicin-induced Cardiotoxicity via the Nrf2 Pathway in Mice.
Fan D; Chen HB; Leng Y; Yang SJ
Curr Med Sci; 2022 Feb; 42(1):48-55. PubMed ID: 35089495
[TBL] [Abstract][Full Text] [Related]
30. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
[TBL] [Abstract][Full Text] [Related]
31. Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death.
Kobayashi S; Volden P; Timm D; Mao K; Xu X; Liang Q
J Biol Chem; 2010 Jan; 285(1):793-804. PubMed ID: 19901028
[TBL] [Abstract][Full Text] [Related]
32. TAF9b (formerly TAF9L) is a bona fide TAF that has unique and overlapping roles with TAF9.
Frontini M; Soutoglou E; Argentini M; Bole-Feysot C; Jost B; Scheer E; Tora L
Mol Cell Biol; 2005 Jun; 25(11):4638-49. PubMed ID: 15899866
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity.
Holmgren G; Synnergren J; Andersson CX; Lindahl A; Sartipy P
Toxicol In Vitro; 2016 Aug; 34():26-34. PubMed ID: 27033315
[TBL] [Abstract][Full Text] [Related]
34. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract][Full Text] [Related]
35. Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p.
Yu X; Ruan Y; Shen T; Qiu Q; Yan M; Sun S; Dou L; Huang X; Wang Q; Zhang X; Man Y; Tang W; Jin Z; Li J
Biomed Res Int; 2020; 2020():5107193. PubMed ID: 32190669
[TBL] [Abstract][Full Text] [Related]
36. Protective role of cezanne in doxorubicin-induced cardiotoxicity by inhibiting autophagy, apoptosis and oxidative stress.
Zhang J; Zha Y; Jiao Y; Li Y; Zhang S
Toxicology; 2023 Feb; 485():153426. PubMed ID: 36639017
[TBL] [Abstract][Full Text] [Related]
37. MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2.
Tong Z; Jiang B; Wu Y; Liu Y; Li Y; Gao M; Jiang Y; Lv Q; Xiao X
Int J Mol Sci; 2015 Jun; 16(7):14511-25. PubMed ID: 26132560
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-22 inhibition prevents doxorubicin-induced cardiotoxicity via upregulating SIRT1.
Xu C; Liu CH; Zhang DL
Biochem Biophys Res Commun; 2020 Jan; 521(2):485-491. PubMed ID: 31677784
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53.
Zhang C; Feng Y; Qu S; Wei X; Zhu H; Luo Q; Liu M; Chen G; Xiao X
Cardiovasc Res; 2011 Jun; 90(3):538-45. PubMed ID: 21278141
[TBL] [Abstract][Full Text] [Related]
40. TBP-associated factor 1 overexpression induces tolerance to Doxorubicin in confluent H9c2 cells by an increase in cdk2 activity and cyclin E expression.
Servant N; Marcantonio D; Th'ng JP; Chalifour LE
Mol Cell Biochem; 2004 Apr; 259(1-2):71-81. PubMed ID: 15124910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]